Optimum side effect management and supportive care are main contributors to the general hazard/gain harmony connected to oncological therapies. This chapter with the In the past recommendations specifics facets which are especially relevant with the cure of breast cancer clients and relies on The newest Variation on the S3 pointers [seventy nine] i